Paige McElfresh, APRN
Nurse Practitioner · Lincoln, NENPI 1114659349
Payments from drug & device makers
Across 33 payments — averaging $22.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$132
- Johnson & Johnson$84
- Sanofi-aventis U.S. LLC$84
- AbbVie$66
- AstraZeneca$39
- Takeda Pharmaceuticals U.S.A., Inc.$38
- plus $305 from 16 others
What the payments were for
- Food & beverage$56475%
- Education$18425%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 3 | $132 |
| Johnson & Johnson | 4 | $84 |
| Sanofi-aventis U.S. LLC | 1 | $84 |
| AbbVie | 3 | $66 |
| AstraZeneca | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Gilead | 2 | $35 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Tersera Therapeutics LLC | 1 | $30 |
| Array Biopharma Inc | 1 | $21 |
| Bayer | 1 | $21 |
| Solventum Corporation | 1 | $18 |
| Merck | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Pfizer | 1 | $14 |
| Medtronic | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Bristol Myers Squibb | 1 | $14 |
| Blueprint Medicines Corporation | 1 | $14 |
How this compares
$748 in reported general payments places this provider in the 70th percentile of 924 nurse practitioner providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 23 | $318 |
| Potassium Chloride | 24 | $238 |
| Oxycodone Hcl | 18 | $144 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 15 | $134 |
| Ondansetron Hcl | 27 | $104 |
| Dexamethasone | 11 | $87 |
| Prochlorperazine Maleate | 12 | $84 |
| Prednisone | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Lincoln
- Lisa OstendorfLincoln$22K
- Jenna BeideckLincoln$9K
- Ann WalkerLincoln$5K
- Denise SpeichLincoln$5K
- Lindy VakocLincoln$5K
- Janice CunninghamLincoln$5K
- Kristen HammesOmaha$899K
- Amy MuchowiczOmaha$78K
- Winifred SchaedelPalmyra$64K
- Kari CunninghamOmaha$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.